Results 21 to 30 of about 699,460 (251)

Burden of typhoid fever and antimicrobial resistance in India (2023): a modelling studyResearch in context [PDF]

The Lancet Regional Health - Southeast Asia
Summary: Background: India is one of the countries with a high typhoid fever burden. In 2022, the National Technical Advisory Group on Immunisation recommended including the typhoid conjugate vaccine (TCV) in the Universal Immunisation Programme.
Vijayalaxmi V. Mogasale, Jacob John, Nikhil Sahai, Arindam Ray, Habib Hasan Farooqui, Vittal Mogasale, Bhim Gopal Dhoubhadel, W. John Edmunds, Andrew Clark, Kaja Abbas   +9 more
doaj   +2 more sources

Effective strategies for typhoid conjugate vaccine delivery: Health and economic insights from the 2015 Kampala outbreak. [PDF]

PLoS Neglected Tropical Diseases
Typhoid fever remains a major public health threat in low- and middle-income countries (LMICs), where inadequate access to clean water and sanitation drives recurrent outbreaks.
Yeonsu Lee, Pamela Kim N Salonga, Changdae Son, Geunsoo Jang, Dae-Hyup Koh, Jong-Hoon Kim, Hyojung Lee   +6 more
doaj   +2 more sources

A new mouse model of typhoid fever using Salmonella enterica serovar Paratyphi C as a surrogate pathogen [PDF]

mBio
Salmonella enterica serovar (S.) Typhi, the etiological agent of typhoid fever, is strictly human adapted, which presents a significant challenge for studying its pathogenesis in animal models.
Hoan T. Pham, Masatomo Morita, Kohei Yamazaki, Toshihiro Endo, Satoshi Takayama, Azusa Hiyoshi, Takeshi Haneda, Renée M. Tsolis, Andreas J. Bäumler, Toshio Kodama, Hirotaka Hiyoshi   +10 more
doaj   +2 more sources

Restoring non-COVID-19 clinical research and surveillance in Oyo state, Nigeria during the SARS-CoV-2 pandemic

Journal of Public Health in Africa, 2022
Background: Many sub-Saharan African patients receive clinical care from extramurally-supported research and surveillance. During the COVID-19 pandemic, pausing these activities reduces patient care, surveillance, and research staff employment ...
Veronica O. Ogunleye, Okainemen P. Oluwalusi, Oluwafemi Popoola, Aderemi Kehinde, Olukemi Adekanmbi, Ifiok Udofia, Sarah Agbi, Ifeoluwa Akintayo, Jolaade J. Ajiboye, Folasade Bamidele, Temitope Alonge, Ondari D. Mogeni, Florian Marks, Iruka N. Okeke   +13 more
doaj   +1 more source

Typhoid vaccine

Reactions Weekly, 2021
Immunologicals
openaire   +2 more sources

Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022

MMWR. Morbidity and mortality weekly report, 2023
Typhoid fever, an acute febrile illness caused by Salmonella enterica serovar Typhi (S. Typhi), is endemic in many low- and middle-income countries† (1).
Molly Hancuh, J. Walldorf, Anna A. Minta, C. Tévi-Bénissan, K. Christian, Yoann Nedelec, K. Heitzinger, M. Mikoleit, A. Tiffany, A. Bentsi-Enchill, L. Breakwell   +10 more
semanticscholar   +1 more source

Experimental evaluation of the possibility of determining bacterial endotoxins in typhoid Vi polysaccharide vaccines using the gel-clot test

Биопрепараты: Профилактика, диагностика, лечение, 2023
Scientific relevance. Currently, only the rabbit pyrogen test is used to test the Vianvac® typhoid Vi polysaccharide vaccine for pyrogenicity. As part of the product specification file, the gel-clot test for bacterial endotoxins (BE) will improve the ...
M. V. Abramtseva, N. S. Alekhina, E. D. Kolyshkina   +2 more
doaj   +1 more source

The effect of a comprehensive typhoid conjugate vaccine campaign on antimicrobial prescribing in children in Harare, Zimbabwe: a mixed methods study

Lancet Global Health, 2023
Summary Background Vaccines prevent infections and could subsequently reduce antimicrobial use. A 1-week mass vaccination campaign was done with Typbar-TCV (Bharat Biotech, Hyderabad, India) between Feb 25 and March 4, 2019.
I. Olaru, R. Chingono, C. Bottomley, Faith R Kandiye, F. Mhino, C. Nyamayaro, Salome Manyau, Michael Vere, Phillomina Chitando, P. Chonzi, T. Darton, J. Dixon, K. Kranzer   +12 more
semanticscholar   +1 more source

Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward

Open Forum Infectious Diseases, 2023
Gavi supports countries to introduce typhoid conjugate vaccine (TCV) with catch-up campaigns. Available TCVs are highly efficacious, equity-focused, and critical to curbing the expansion of antimicrobial resistance.
A. Russell, L. Hampton, Antara Sinha, F. Luquero, Jalaa' Abdelwahab   +4 more
semanticscholar   +1 more source

Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products

Биопрепараты: Профилактика, диагностика, лечение, 2021
Typhoid fever is an acute infectious disease caused by Salmonella enterica subsp. enterica serovar Typhi (S. Typhi), which is still extremely common in endemic low- and middle-income countries of Asia and Africa.
M. V. Abramtseva, E. O. Nemanova, N. S. Alekhina, T. I. Nemirovskaya   +3 more
doaj   +1 more source